Room 4331, 3th building, high-tech industrial park, yizhi road, qingshan district, wuhan, China
Home ProductsOral Anabolic steroids

Natural 17 A Hydroxyprogesterone Caproate , CAS 630-56-8 Bodybuilding Oral Steroids

Natural 17 A Hydroxyprogesterone Caproate , CAS 630-56-8 Bodybuilding Oral Steroids

    • Natural 17 A Hydroxyprogesterone Caproate , CAS 630-56-8 Bodybuilding Oral Steroids
    • Natural 17 A Hydroxyprogesterone Caproate , CAS 630-56-8 Bodybuilding Oral Steroids
    • Natural 17 A Hydroxyprogesterone Caproate , CAS 630-56-8 Bodybuilding Oral Steroids
    • Natural 17 A Hydroxyprogesterone Caproate , CAS 630-56-8 Bodybuilding Oral Steroids
  • Natural 17 A Hydroxyprogesterone Caproate , CAS 630-56-8 Bodybuilding Oral Steroids

    Product Details:

    Place of Origin: Hubei,China
    Brand Name: Bodybiological
    Certification: ISO9001, SGS
    Model Number: CAS:630-56-8

    Payment & Shipping Terms:

    Minimum Order Quantity: 10gram
    Price: USD1/gram
    Packaging Details: Foil bag
    Delivery Time: within 24hours
    Payment Terms: T/T, Western Union, MoneyGram
    Supply Ability: 100kg/month
    Contact Now
    Detailed Product Description
    Keywords: 17A-hydroxyprogesterone Hexanoate Alias: Hydroxyprogesterone Caproate
    CAS: 630-56-8 Appearance: White Powder
    Shipping Method: FEDEX, TNT, DHL, UPS, HK EMS Payment Terms: Money Gram, Western Union, Bank Transfer
    MOQ: 10gram Purity: 99.8%
    Export Market: USA, UK, Thailand, Brazil, Canada Brand: Bodybiological

    CAS 630-56-8 Natural Hydroxyprogesterone Caproate 17A-hydroxyprogesterone Hexanoate

     

    Basic information:

     

    Product Description
    Progesterone Hormones Powders 17A-Hydroxyprogesterone caproate CAS 630-56-8
    What is the 17A-Hydroxyprogesterone caproate CAS 630-56-8?
    17α-Hydroxyprogesterone caproate is a synthetic steroid hormone that is similar to medroxyprogesterone acetate and megestrol acetate. It is an ester derivative of 17α-hydroxyprogesterone formed from caproic acid (hexanoic acid).

     

    COA:

     

    Standard:USP31
    Items Standard Resutls
    Description White or almost white crystalline powder, odorless Conforms
    Solubility insoluble in water, solube in ether, slightly soluble in benzene Conforms
    Specific Optical Rotation +58°---+64° (1% chloroform Solution) 60.3°
    Melting Point about 120 -124 ºC 123ºC
    Water ≤0.1% 0.05%
    Free N-Caproic Acid ≤0.58% 0.20%
    Ordinary Impurities ≤2.0% conforms
    Residual Solvents Methanol ≤ 3000PPM 1280PPM
    Ethanol≤5000PPM 1500PPM
    Dichloromethane ≤ 600PPM 80PPM
    Assay 97.0%--103.0% 99.30%
    Conclusion Conforms to USP31  

     

    Applications:

     

    Hydroxyprogesterone caproate (OHPC) (INN, USAN, JAN) (brand names Delalutin, Proluton, Makena, Prodrox, Hylutin, many others), also known as hydroxyprogesterone hexanoate (BANM), is a steroidal progestin and derivative of 17α-hydroxyprogesterone (17α-OHP) that is related to other 17α-OHP derivatives such as chlormadinone acetate, cyproterone acetate, medroxyprogesterone acetate, and megestrol acetate. It is an ester of 17α-OHP formed from caproic acid (hexanoic acid).

     

    OHPC was previously marketed under the trade name Delalutin by Squibb, which was approved by the United States (U.S.) Food and Drug Administration (FDA) in 1956 and withdrawn from marketing in 1999.[5] It is also sold as Proluton throughout Europe. The U.S. FDA approved Makena from KV Pharmaceutical (previously named as Gestiva) on February 4, 2011 for prevention of preterm delivery in women with a history of preterm delivery, sparking a pricing controversy.

     

    The use of OHPC in pregnancy to prevent preterm birth in women with a history of preterm delivery between 20 weeks and 36 weeks and 6 days is supported by the Society of Maternal Fetal Medicine Clinic Guidelines put out in May 2012 as Level I and III evidence, Level A recommendation.[6] Level I evidence refers to a properly powered randomized controlled trial, and level III evidence is support from expert opinion, while a Level A recommendation confers that the recommendation is made based on good and consistent scientific evidence. OHPC 250 mg IM weekly preferably starting at 16–20 weeks until 36 weeks is recommended. In these women, if the transvaginal ultrasound cervical length shortens to <25 mm at < 24 weeks, cervical cerclage may be offered. In the 2013 study the guideline recommendation is based on,[7] there was also a significant decrease of neonatal morbidity including lower rates of necrotizing enterocolitis (0 in the treatment group vs 4 in the control), intraventricular hemorrhage (4 in the treatment group compared with 8 in the control for a relative risk of 0.25), and need for supplemental oxygen (14% in the treatment group vs 24% in the placebo for a relative risk of 0.42). Furthermore, this study contained 463 patients, 310 of whom received injection. Of these patients, 9 had infants with congenital malformations (2%), but there was no consistent pattern and none involved internal organs.

     

    Other related products:

     

    TEST ITEMS SPECIFICATION RESULTS
    Description White or Almost White Crystalline Powder white powder
    Identification A.B. Positive
    Assay 97.0~103.0% 99.3%
    Specific Rotation +101°~+105° +102.6°
    Our Advantages
    Loss On Drying
    1.0%max 0.27%
    Melting Point 153~157°C 153.0~155.0°C
    Organic Volatile Impurities Meets the requirement. Conforms
    Related Substances Meets the requirement. Conforms
    Residual Solvents Meets the requirement. Conforms
    Particle Size 100% ≤ 20 microns Conforms
    Conclusion The specification conform with USP30 standard

     

    Natural 17 A Hydroxyprogesterone Caproate , CAS 630-56-8 Bodybuilding Oral Steroids

    Contact Details
    Wuhan Body Biological Co.,Ltd

    Contact Person: Penny

    Tel: +8613429837396

    Send your inquiry directly to us (0 / 3000)

    Other Products